These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
    Author: Xu JX, Yang Y, Zhang X, Luan XP.
    Journal: Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561.
    Abstract:
    OBJECTIVE: This study aimed to explore the effects of microRNA-29b (miR-29b) on chemoresistance of glioma and to examine the underlying mechanisms. MATERIALS AND METHODS: MiR-29b expression in glioma tissues and cell lines was analyzed by quantitative real time-polymerase chain reaction (qRT-PCR). The cell viability was determined by Cell Counting Kit-8 (CCK-8) assay. Cell apoptosis was analyzed by Annexin V-Fluorescein isothiocyanate (FITC) assay. The relationship between miR-29b and signal transducer and activator of transcription 3 (STAT3) was examined by the Dual-Luciferase reporter gene assay. The levels of cleaved caspase-3, Bax, Bcl-2, and STAT3 were detected by Western blotting assay. RESULTS: The expression of miR-29b was downregulated in glioma tissues compared to normal brain tissue. In addition, the expression level of miR-29b was lower in glioma tissues from patients at late stages (III and IV) compared with early stages (I and II). Besides, miR-29b expression was significantly lower in LN229, U87MG, and U251 cells compared to normal human astrocytes (NHA) cells. Moreover, our results showed that miR-29b expression in Temozolomide (TMZ)-resistance cell lines U251/TMZ and U87MG/TMZ was markedly lower than that of TMZ-sensitivity cell lines U251 and U87MG. The protein levels of STAT3 and the phosphorylation of STAT3 were increased in U251/TMZ and U87MG/TMZ compared to U251 and U87MG. When the expression of miR-29b was repressed, cell viability was increased. Meanwhile, cell apoptosis was reduced, the protein levels of cleaved caspase-3 and (Bcl-2 Associated X Protein) Bax were decreased, whereas the protein level of B-cell lymphoma 2 (Bcl-2) was increased. Moreover, the effects of miR-29b knockdown on the cell growth and apoptosis in U251 and U87MG cells were markedly attenuated by knockdown of STAT3. In TMZ-resistant U251/TMZ and U87MG/TMZ cells, transfection with miR-29b decreased cell growth, promoted apoptotic cell death, elevated the protein levels of cleaved caspase-3, and Bax protein, while downregulated Bcl-2 protein. As expected, the effect of miR-29b upregulation on cell growth and apoptosis of TMZ-resistant glioma cells was reversed by STAT3 overexpression. The results from the Luciferase assay demonstrated miR-29b modulated STAT3 expression by directly bound with 3'-Untranslated Region (3'-UTR). CONCLUSIONS: MiR-29b enhances the cell sensitivity to TMZ by inhibiting STAT3 in glioma. Our study might provide a novel target for treating TMZ-resistant glioma.
    [Abstract] [Full Text] [Related] [New Search]